We just received data on a new analyst forecast for $SLNO. Guggenheim gave a rating of 'Buy' for $SLNO.
$SLNO Analyst Ratings
Wall Street analysts have issued reports on $SLNO in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 08/27/2025
- Wells Fargo issued a "Overweight" rating on 08/20/2025
- Oppenheimer issued a "Outperform" rating on 08/07/2025
- Baird issued a "Outperform" rating on 07/11/2025
- Piper Sandler issued a "Overweight" rating on 04/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 04/15/2025
- Stifel issued a "Buy" rating on 03/28/2025
To track analyst ratings and price targets for $SLNO, check out Quiver Quantitative's $SLNO forecast page.
$SLNO Price Targets
Multiple analysts have issued price targets for $SLNO recently. We have seen 9 analysts offer price targets for $SLNO in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Debjit Chattopadhyay from Guggenheim set a target price of $106.0 on 08/27/2025
- Derek Archila from Wells Fargo set a target price of $123.0 on 08/20/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $110.0 on 08/18/2025
- Leland Gershell from Oppenheimer set a target price of $110.0 on 08/07/2025
- Brian Skorney from Baird set a target price of $121.0 on 07/11/2025
- Yasmeen Rahimi from Piper Sandler set a target price of $145.0 on 04/24/2025
- James Condulis from Stifel set a target price of $108.0 on 03/28/2025
$SLNO Insider Trading Activity
$SLNO insiders have traded $SLNO stock on the open market 74 times in the past 6 months. Of those trades, 0 have been purchases and 74 have been sales.
Here’s a breakdown of recent trading of $SLNO stock by insiders over the last 6 months:
- OPPORTUNITY, LLC VIVO has made 0 purchases and 3 sales selling 1,833,557 shares for an estimated $124,449,124.
- BHATNAGAR ANISH (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 12 sales selling 699,095 shares for an estimated $47,271,960.
- PATRICIA C HIRANO (SEE REMARKS) has made 0 purchases and 19 sales selling 164,193 shares for an estimated $11,313,890.
- KRISTEN YEN (SEE REMARKS) has made 0 purchases and 10 sales selling 95,500 shares for an estimated $6,376,788.
- JAMES H MACKANESS (CHIEF FINANCIAL OFFICER) has made 0 purchases and 11 sales selling 90,622 shares for an estimated $6,293,177.
- MEREDITH MANNING (Chief Commercial Officer) has made 0 purchases and 9 sales selling 45,249 shares for an estimated $3,044,342.
- MICHAEL F. HUANG (Sr. VP of Clinical Development) has made 0 purchases and 9 sales selling 14,583 shares for an estimated $1,013,627.
- MATTHEW PAULS sold 5,937 shares for an estimated $424,797
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SLNO Hedge Fund Activity
We have seen 156 institutional investors add shares of $SLNO stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,104,385 shares (+49.4%) to their portfolio in Q2 2025, for an estimated $92,525,375
- PERCEPTIVE ADVISORS LLC removed 1,076,163 shares (-71.4%) from their portfolio in Q2 2025, for an estimated $90,160,936
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,061,064 shares (+44.2%) to their portfolio in Q2 2025, for an estimated $88,895,941
- VESTAL POINT CAPITAL, LP removed 1,060,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $75,737,000
- BLACKROCK, INC. added 931,421 shares (+48.7%) to their portfolio in Q2 2025, for an estimated $78,034,451
- POINT72 ASSET MANAGEMENT, L.P. removed 915,995 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $76,742,061
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 816,732 shares (-18.6%) from their portfolio in Q2 2025, for an estimated $68,425,806
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
